Join us for an insightful webinar highlighting how Risk-Based Quality Management (RBQM) can empower M&A and investment decisions in the pharmaceutical industry. Discover how RBQM enhances clinical due diligence processes, supporting areas like data integrity and risk assessment. We’ll explore methodologies and potential findings that drive data-driven decision-making, ultimately showcasing the benefits of gaining actionable…Continue reading mindsON RBQM | Special Edition – M&A Efficiency: RBQM supported Clinical Due Diligence (Webinar | Online)